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PHARMACY
Antibiotic-Loaded Bone Cement (ALBC)
Dr Ale Zehra, Clinical Pharmacist  
Infections in orthopedic surgery are a serious issue. Antibiotic-loaded bone 
cement was developed (FDA Approved) for the treatment of infected joint 
arthroplasties and for prophylaxis in total joint replacement. Bone cement 
is composed of poly-methyl-methacrylate (PMMA) or copolymers, is a 
polymeric material commonly used for the fixation of the joint implants 
to the bone. The mechanism by which antibiotic elutes from PMMA is 
not fully understood but generally is thought to be a passive phenomenon 
in which antibiotic diffuses out of pores, cracks, and voids in the cement. 
Most studies evaluating combinations of antibiotics have demonstrated a 
synergistic effect, in that adding a second antibiotic seems to increase the 
elution of both antibiotics.1, 2, 3
Characteristic of the Antibiotic: Antibiotic must;
	 	have powder preparation
	 	reduce interference with the mechanical properties of the cement.
	 	have broad antibacterial spectrum (including gram positive and 
  gram negative bacteria), low percentage of resistant species, 
	 	be heat stable and  hydrophilic nature, Good tissue/bone  
  penetration and elution from cement.
	  provide a local concentration able to overcome the “break point 
  sensitivity limit” of pathogens.4,5
Common Antibiotic used for Cement Bone:
Many antibiotics have been shown to maintain efficacy when mixed with 
PMMA. The most commonly used antibiotics and their dosage is listed in table 
01. 5,6
Table 1: 
Antibiotic 
Gentamicin 
Vancomycin 
Piperacillin/
tazobactam
Meropenem 
Colistin
Cefazolin
Teicoplanin
Usual Dose for Cement Beads
Commercially available with cement ( each  40gm contains 
1.0 M.I.U of Gentamicin)
2gm  - 4gm
9gm
2gm – 4gm
9 M.I.U
2gm – 4gm
2 gm
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FDA Safety Alerts 2016 & 2017 
Dr Afia Rais, Trainee Pharmacist
Drug/Class 
Tramadol & 
Codeine
Opioids
Metformin 
containing drugs
Fluconazole
Aripiprazole
Olanzapine
Fluoroquinolones
Ketoconazole
Sumatriptan
Month 
April
March
April
April
May
May
May
May
June
Safety Update
2017
n FDA restricts use of prescription codeine (children younger than 12 years) pain and   
 cough medicines and tramadol (children younger than 18 years) pain medicines in   
 children; recommends against use in breastfeeding women.
Note: AKUH Karachi does not have codeine preparation but tramadol is available as our formularly drug.
2016 
n Concomitant administration of opioids and antidepressant can result in serotonin 
 syndrome, in which high levels of the chemical serotonin build up in the brain and 
 cause toxicity.
n Taking opioids may lead to decreased production of adrenal hormone cortisol which 
 produce symptoms such as nausea, vomiting, loss of appetite, fatigue, dizziness, or 
 low blood pressure.
n Metformin can be used safely in patients with mild impairment in kidney function and 
 in some patients with moderate impairment in kidney function.
n Caution is advised for prescribing oral fluconazole in pregnancy as there is a possible  
 increased risk of miscarriage.
n Aripiprazole use is associated with compulsive behaviors and uncontrollable urges   
 such as gamble, binge eat, shop, and sexual activities.
n Olanzapine can cause a rare and serious skin reaction called DRESS (Drug Reaction   
 with Eosinophilia and Systemic Symptoms) which results in rash, fever and swollen   
 lymph nodes, swollen face, organ injury, and can even lead to death.
n Fluoroquinolones should be reserved for final treatment options because it can cause   
 disabling and potentially permanent serious side effects involving the tendons,   
 muscles, joints, nerves, and central nervous system.
n Prescribing of ketoconazole oral tablets for unapproved uses (skin and nail fungal \
 infections) is outweighed by risk of serious liver damage, adrenal gland problems, and 
 harmful drug interactions. 
n Use of sumatriptan transdermal patch for migraine headaches can cause serious burns 
 and potential permanent scarring, severe redness, pain, skin discoloration, blistering, 
 and cracked skin.
Reference:
1.  Bistolfi A, Massazza G, Verné E, Massè A, Deledda D, Ferraris S, Miola M, Galetto F, Crova M. Antibiotic-loaded cement in orthopedic  
 surgery: a review. ISRN orthopedics. 2011Aug 7; 2011.
2. D. Hanssen, “Prophylactic use of antibiotic bone cement: an emerging standard—In opposition,” Journal of Arthroplasty, vol. 19, no. 4, 
 supplement 1, pp. 73–77, 2004. 
3. R. B. Bourne, “Prophylactic use of antibiotic bone cement: an emerging standard—in the affirmative,”  Journal of Arthroplasty, vol. 19, no. 4, 
 supplement 1, pp. 69–72, 2004. 
4. L. Frommelt and K. D. Kuhn, “Properties of bone cement: antibiotic loaded cement,” in The Well-Cemented Total Hip Arthroplasty, part II,  
 pp. 86–92, Springer, Berlin, Germany, 2006. 
5. G. E. Hendriks, J. R. van Horn, H. C. van der Mei, and H. J. Busscher, “Backgrounds of antibiotic-loaded bone cement and prosthesis-related 
 infection,” Biomaterials, vol. 25, no. 3, pp. 545–556, 2004. 
6. H. van de Belt, D. Neut, W. Schenk, J. R. van Horn, H. C. van der Mei, and H. J. Busscher, “Infection of orthopedic implants and the use of  
 antibiotic-loaded bone cements: a review,” Acta Orthopaedica Scandinavica, vol. 72, no. 6, pp. 557–571, 2001
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www.fda.gov/Drugs/DrugSafety
Antimicrobials Induced Mental Changes
Dr Kashif Hussain, Specialist, Infectious Disease 
Drug/Class 
Loperamide
Opioids with 
benzodiazepines
Testosterone
Pioglitazone
General anesthetic 
and sedation drugs
BupropionDrug/Cl
Month 
June
August
October
December
December
DecemberM
Safety Update
n Taking higher than recommended doses of loperamide can cause serious heart 
 problems, QT interval prolongation, Torsades de Pointes or other ventricular 
 arrhythmias, syncope, and cardiac arrest and can lead to death.
n Combined use of opioid medicines with benzodiazepines or other CNS depressant   
 may result  in serious side effects, including slowed or difficult breathing and deaths.
n Abuse of testosterone and other anabolic androgenic steroids at higher doses can affect 
 the heart, brain, liver, mental health, and endocrine system and cause withdrawal 
 symptoms.
n Use of the antidiabetic medicine pioglitazone  may be linked to an increased risk of   
 bladder cancer and should not be used in patients with active bladder cancer.
n Repeated or prolong use of general anesthetic and sedation drugs during surgeries in 
 children younger than 3 years or in pregnant women during their third trimester may   
 affect the development of children brains.
n The risk of serious side effects on mood, behavior, or thinking with bupropion is lower  
 than previously suspected and the benefits outweigh the risks of these medicines for 
 smoking cessation.
Antimicrobial Class
Fluoroquinolones
Cephalosporin: Most 
common: cefepime,
ceftazidime, cefazolin
Penicillins: Most com-
mon: piperacillin/ tazo-
bactam
Carbapenems: Most 
common: imipenem,
ertapenem
Macrolides: Most 
common: clarithromycin, 
erythromycin
Sulfonamides: Most 
common: TMP/SMX
Amebicide: Most 
common Metronidazole 
Most Common Presentation 
of Neurotoxicity
Acute psychosis, Confusion, 
Delirium, Hallucinations, Mania
Confusion, Delirium, NCSE  
Seizures
Bizarre behavior, Confusion,
Delirium, Disorientation 
Hallucinations NCSE Seizures
Cognitive impairment, Delirium, 
Hallucinations,Psychosis syndrome
Seizures
Acute psychosis, Delirium, Mania
Acute psychosis, Aseptic meningi-
tis, Hallucinations
Agitation, Altered mental status, 
Cerebellar dysfunction, 
Encephalopathy,Ototoxicity, 
Risk Factors
Age (possibly)
Age, Preexisting neurologic
disease, Renal impairment/improper dose for patients 
creatinine clearance
Age, Preexisting neurologic
disease.  Renal impairment (especially Crcl<15mL/min)
 and/or dialysis
Age, Preexisting neurologic disease, Renal impairment
Age , Cytochrome P450 3A4 substrates
Age (especially in HIV-infected patients) Dose Renal 
impairment
Cumulative exposure
Use in combination with disulfiram
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Drug Induced Osteoporosis and Role of Pharmacists
Zainab Qadri, Trainee Pharmacist
Osteoporosis is a disease characterized by low bone mineral density and deterioration of the bone architecture 
leading to increased fragility and fractures. Osteoporosis may be disease induced hypogonadism (low levels 
of testosterone), alcohol abuse, smoking, gastrointestinal disease, hypercalciuria, and immobilization or drug 
induced. Drug-induced includes: 1
a) Glucocorticoid Induced Osteoporosis (GIOP) – (for e.g. Prednisolone)
b) Hormonal Therapies:
 1. Aromatase inhibitors (AI) - (for e.g. Anastrazole , Letrozole)
 2. Gonadotropin releasing hormone(GnRH) agonist - (for e.g. Goserelin, Leuprolide) 
 3. Depomedroxyprogesterone acetate (DMPA)
 4. Thyroid replacement therapy
c) Central nervous system agents:
 1. Anticonvulsants -( for e.g. Carbamazepine, Phenobarbital And Phenytoin)
 2. Antidepressants - (for e.g. SSRI’s, TCAs)
 3. Antipsychotics- (for e.g. Haloperidol)
Reference:
1. Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology. 2016;  
 86:963-971. 
2. Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clin Ther. 2014; 36:1489-1503. 
3. Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of  
 severe, underappreciated encephalopathy. Crit Care. 2013; 17:R264.
4. Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol. 2011; 
 72:381-393. 
Antimicrobial Class
Oxazolidinones:   Most 
common: Linezolid
Antifungals:
Most common: Voricon-
azole Azole 
Antiviral: Most common 
Acyclovir
Antiviral: Most common 
Oseltamivir
Antiviral: Amantadine 
and Rimantadine 
Most Common Presentation 
of Neurotoxicity
Peripheral neuropathy, Psychosis 
Seizures
Delirium, Encephalopathy,
Peripheral neuropathy, 
Serotonin syndrome.
Delirium, Hallucinations
 
Confusion, Impaired, 
consciousness
Anxiety, Behavioral change, 
Delirium, Delusions, Convulsions, 
Encephalitis, Sleep disturbances 
Suicidal ideation
Anxiety, Behavioral change, 
Delirium
Hallucinations, Nervousness
Risk Factors
Age, Alcohol abuse, Concomitant, serotonergic drugs. 
Diabetes, Preexisting neurologic disease.
Serum Voriconazole concentration >5.5 µg/mL
 
Dose, Renal impairment
Age , Genetic differences (possibly)
Age, Psychiatric disorder, Renal impairment Seizure disorder
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d) Gastric Acid Reducing Agents:
 1. Proton pump inhibitors - (for e.g. Omeprazole, Esomeprazole etc) 
Pharmacists are in a unique position to help reduce the burden of osteoporosis by improving the identification 
of high-risk patients for treatment, especially those on corticosteroid therapy.1 Community pharmacies provide 
an ideal setting for osteoporosis risk assessment, patient screening and interventions.2  Pharmacists should be 
familiar with drugs suspected of causing drug related osteoporosis, risk of fracture associated with specific 
agents and patients taking such drugs. Several studies1,2,3,4 suggest that pharmacist identification and counsel-
ing of patients at risk for osteoporosis help in reduction of disease.  
References:
 1. O’Connell  MB, Vondracek SF, Osteoporosis and other metabolic bone diseases. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells  
  BG, Posey LM eds. 
  Pharmacotherapy: A pathophysiologic Approach, 7th ed, New York: Mc Graw Hill Medical, 2008 [12]:1483-504
 2. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–543. 
 3. Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmaco 
  ther. 2005;39:1527–1533. DOI: 10.1345/aph.1E456. 
 4. Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized 
  controlled trial. Osteoporos Int. 2010;21:391–398.
Parenteral Applications of Ketogenic Diet Therapy
Kanwal Saleem, Pharmacist 
The ketogenic diet is a well-accepted treatment modality for children with intractable epilepsy and for inborn 
errors of carbohydrate metabolism. These children, just as any other child, may be faced with short-term or 
long-term medical conditions that require parenteral nutrition (PN)1. Ketogenic diet therapy is a high fat, low 
carbohydrate and moderate protein regimen that results in a sustained metabolic state of ketosis.1, 2, 3 Some 
clinical studies of ketogenic diet proved that patients who are on ketogenic diet showed an increased GABA 
levels in the cerebrospinal fluid, eventually decrease the seizure threshold. 
Ketogenic Parenteral nutrition: This nutrition conventionally consists of intravenous fat emulsion plus dex-
trose and amino acid in hyperalimentation, infused during a bowel rest. 
 
Parameters before Initiation of Therapy:
 1- Monitor for hypoglycemia, hydration, ketosis, seizure response & carbohydrate intake.
 2- Verify that all medications/fluids/supplements are carbohydrate free.
 3- The administration of Carnitine should be considered along with a high-fat or ketogenic TPN 
  solution. Carnitine facilitates the transport of fatty acids from long chain fats into the mitochondria.
The macronutrient contents of typical Parenteral Nutrition (PN) solution are; 50% to 60% carbohydrate, 10% 
to 20% amino acids, and 20% to 30% fat whereas the ratios of these macronutrients in ketogenic parenteral 
nutrition are as 
5
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The Aga Khan University Hospital, Karachi
Provide us your Valuable Feedback!
To keep the Pharmacy Newsletter of Aga Khan University Hospital (AKUH) updated we would like to take your valuable feedback. We are grateful 
to you for sparing few minutes of your precious time to complete form by below online link or form can be emailed to you as well. Just drop us an 
email with subject Newsletter Feedback. Email us at:drug.information@aku.edu 
Thank you in advance for your feedback! 
Link: 
https://goo.gl/forms/Ghh1Nc2KY2jEkiUL2
Table 01: Energy Distribution of Diet 
4:1
90 %
10 %
Ratio 
Gms of lipid : gms 
of  protein & 
carbohydrate
Lipid
Protein &  
Carbohydrate
( non –lipid ) 
3:1
87 %
13 %
2:1
80 %
20 %
1:1
70 %
30%
Regular PN
20-30 %
Protein 10 to 20 %
Carbohydrates 
50-60%
Due to lack of published literature on this matter, case studies and further investigational studies are required 
to develop evidence-based best practice guidelines and more thoroughly evaluate the safety of long-term keto-
genic PN.1
References:
1. Roan M. Management of long-term ketogenic parenteral nutrition. ICAN: Infant, Child, & Adolescent Nutrition. 2011 Oct; 3(5):282-7. 
2. Zupec-Kania BA, Aldaz V, Montgomery ME, Kostas KC. Enteral and parenteral applications of ketogenic diet therapy: Experiences from 
 four centers. ICAN: Infant, Child, & Adolescent Nutrition. 2011 Oct; 3(5):274-81.
3. Acton, Q.Ashton PhD, Brain diseases-advances in research and applications: 2013 edition.
4. McNally MA, Hartman AL. Ketone bodies in epilepsy. Journal of neurochemistry. 2012 Apr 1; 121(1):28-35.
Energy Distribution in ketogenic & regular parenteral Nutrition
